CNBX Pharmaceuticals

📍 Bethesda, United States🗓 Founded 2012👥 11 employees💰 Last funded Oct 2016
Pharmaceutical Manufacturing🌐 CNBXpharma.com
Website LinkedIn
CNBX Pharmaceuticals is a publicly traded company (CNBX: OTCQB) and developer of the world’s first cannabinoid-based antitumor drug candidate for the treatment of colorectal cancer based on the company's novel and proprietary formulation CNBX™️ RCC-33.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2012
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Israel
1
Frequently asked questions
Who invested in CNBX Pharmaceuticals?
CNBX Pharmaceuticals has 1 investors on record on gritt.io, 1 mid-stage.
When did CNBX Pharmaceuticals last raise funding?
The most recent investment in CNBX Pharmaceuticals recorded on gritt.io was in October 2016.
When was CNBX Pharmaceuticals founded?
CNBX Pharmaceuticals was founded in 2012.
What industry is CNBX Pharmaceuticals in?
CNBX Pharmaceuticals operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is CNBX Pharmaceuticals based?
CNBX Pharmaceuticals is headquartered in Bethesda, United States.